Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$4.22M-$4.22MderivedN/M vs Q4 2024 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,261,703N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,657,101N/M Free Cash Flowderived-$3,660,690N/M ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end